News

Nova Mentis Files Patent on Diagnosing, Monitoring and Treating Neurological Diseases with Psychoactive Tryptamine Derivatives

mRNA Diagnostic Index to Measure Drug Treatment ResponseVancouver, British Columbia--(Newsfile Corp. - June 16, 2022) - Nova Mentis Life Science…

2 years ago

CBD of Denver Accelerates Expansion Plans with Strategic Priorities Set for Second Half of 2022

Denver, Colorado--(Newsfile Corp. - June 16, 2022) -  CBD of Denver, Inc. (OTC Pink: CBDD), a cannabis roll-up company and…

2 years ago

Emerald Health Therapeutics Provides Bi-Weekly MCTO Status Update

Vancouver, British Columbia--(Newsfile Corp. - June 16, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the…

2 years ago

Biote Appoints Ross W. McQuivey, M.D. as Chief Medical Officer

 Innovative physician leader brings over 20 years of experience to Biote’s executive team IRVING, Texas--(BUSINESS WIRE)--biote Corp. (“Biote” or the…

2 years ago

Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic

Innovation Passport Awarded to Molgramostim for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP), a Rare Lung Disease The Innovation…

2 years ago

Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System

The long-term implantable E3 CGM system now approved for commercialization in select European markets GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE…

2 years ago

Encision Reports Fourth Quarter Fiscal Year 2022 Results

BOULDER, CO / ACCESSWIRE / June 16, 2022 / Encision Inc. (OTCPK:ECIA), a medical device company owning patented Active Electrode…

2 years ago

Biophytis Presents Preclinical Efficacy Data for Sarconeos (BIO101) in Spinal Muscular Atrophy (SMA), a Rare Neuromuscular Disease

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / June 16, 2022 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis" or…

2 years ago

Angle PLC Announces Predicting Immunotherapy Response in SCLC

PARSORTIX SYSTEM DEMONSTRATES POTENTIAL IN PREDICTING IMMUNOTHERAPY RESPONSE IN SMALL CELL LUNG CANCERCTCs isolated by the Parsortix system can be…

2 years ago

AngioDynamics to Report Fiscal 2022 Fourth Quarter and Full-Year Financial Results on July 12, 2022

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in…

2 years ago